These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37760741)

  • 1. In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement.
    Sánchez-Somolinos M; Díaz-Navarro M; Benjumea A; Matas J; Vaquero J; Muñoz P; Sanz-Ruíz P; Guembe M
    Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an
    Sánchez-Somolinos M; Díaz-Navarro M; Benjumea A; Tormo M; Matas J; Vaquero J; Muñoz P; Sanz-Ruíz P; Guembe M
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
    Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
    Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin elution, activity and impact on mechanical properties when added to orthopedic bone cement.
    Bishop AR; Kim S; Squire MW; Rose WE; Ploeg HL
    J Mech Behav Biomed Mater; 2018 Nov; 87():80-86. PubMed ID: 30048880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus.
    Jacob B; Makarewicz O; Hartung A; Brodt S; Roehner E; Matziolis G
    Sci Rep; 2021 Dec; 11(1):23425. PubMed ID: 34873186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial biofilm formation is variably inhibited by different formulations of antibiotic-loaded bone cement in vitro.
    Balato G; Roscetto E; Vollaro A; Galasso O; Gasparini G; Ascione T; Catania MR; Mariconda M
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1943-1952. PubMed ID: 30370437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-Loaded Polymethylmethacrylate Spacers Fail to Eradicate Periprosthetic Joint Infection in a Clinically Representative Mouse Model.
    Carli AV; Bhimani S; Yang X; de Mesy Bentley KL; Ross FP; Bostrom MPG
    J Bone Joint Surg Am; 2018 Jun; 100(11):e76. PubMed ID: 29870449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis.
    Barnea Y; Lerner A; Aizic A; Navon-Venezia S; Rachi E; Dunne MW; Puttagunta S; Carmeli Y
    J Antimicrob Chemother; 2016 Feb; 71(2):460-3. PubMed ID: 26518048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro elution characteristics of antibiotic-loaded polymethylmethacrylate cement and a calcium sulfate bone substitute using staphylococci isolated from orthopedic implant-associated infections.
    Batista Campos L; Kurihara MNL; Santos INM; Dos Reis FB; Salles MJ
    J Biomed Mater Res B Appl Biomater; 2023 Jun; 111(6):1318-1327. PubMed ID: 36779478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics in Bone Cements Used for Prosthesis Fixation: An Efficient Way to Prevent
    Cara A; Ballet M; Hemery C; Ferry T; Laurent F; Josse J
    Front Med (Lausanne); 2020; 7():576231. PubMed ID: 33553196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different microbial biofilm formation on polymethylmethacrylate (PMMA) bone cement loaded with gentamicin and vancomycin.
    Bertazzoni Minelli E; Della Bora T; Benini A
    Anaerobe; 2011 Dec; 17(6):380-3. PubMed ID: 21515396
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Rubia M; Cordero A; Pérez-Granda MJ; Cercenado E; Pascual C; Muñoz P; Guembe M
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.
    Jabés D; Candiani G; Romanó G; Brunati C; Riva S; Cavaleri M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1118-23. PubMed ID: 15047510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo.
    Darouiche RO; Mansouri MD
    J Infect; 2005 Apr; 50(3):206-9. PubMed ID: 15780414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
    Aslan H; Yapar N
    Mikrobiyol Bul; 2015 Oct; 49(4):475-83. PubMed ID: 26649405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times.
    Di Pilato V; Ceccherini F; Sennati S; D'Agostino F; Arena F; D'Atanasio N; Di Giorgio FP; Tongiani S; Pallecchi L; Rossolini GM
    Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114901. PubMed ID: 31761480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds.
    Žiemytė M; Rodríguez-Díaz JC; Ventero MP; Mira A; Ferrer MD
    Front Microbiol; 2020; 11():553. PubMed ID: 32362877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin.
    Oliva A; Stefani S; Venditti M; Di Domenico EG
    Front Microbiol; 2021; 12():749685. PubMed ID: 34745053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.